The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Aravive, Inc(NASDAQ:ARAV) 
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases. Its lead product candidate is AVB-500, a decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase Ib/II clinical trial for the treatment of platinum- resistant recurrent ...
Website: http://www.aravive.com
Founded: 2008
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology
Aravive Days Payable Outstanding ttm (DPO)
Aravive Days Receivable Outstanding ttm (DSO)
Aravive Op Cashflow Per Share ttm
Aravive Free Cashflow Per Share ttm
Aravive Cash Per Share ttm
Aravive P/S ratio ttm
Aravive (GAAP) P/E ratio ttm
Aravive P/B ratio ttm
No extra charts and metrics for this ticker.